The Future of Oncolytic Virus Manufacturing: AI, Personalized Therapies, and Scalable Production
The oncolytic virus CDMO services market is on the cusp of a transformative era that will fundamentally redefine how cancer therapies are developed and manufactured. The convergence of artificial intelligence, personalized medicine, and advanced manufacturing technologies is creating a new paradigm where oncolytic virus therapies become more targeted, scalable, and accessible. As we look toward...
0 Commentarios 0 Acciones 153 Views 0 Vista previa